Free Trial

Anika Therapeutics (ANIK) Earnings Date, Estimates & Call Transcripts

$25.64
+0.88 (+3.55%)
(As of 05/29/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 8)
$0.09 Missed By -$0.04
Consensus EPS
(May. 8)
$0.13
Skip Charts & View Estimated and Actual Earnings Data

ANIK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANIK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Anika Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.28)($0.28)($0.28) 
Q2 20241$0.23$0.23$0.23 
Q3 20241$0.34$0.34$0.34 
Q4 20241$0.43$0.43$0.43 
FY 20244$0.72$0.72$0.72 
Q1 20251$0.22$0.22$0.22 
Q2 20251$0.26$0.26$0.26 
Q3 20251$0.39$0.39$0.39 
Q4 20251$0.44$0.44$0.44 
FY 20254$1.31$1.31 $1.31

ANIK Earnings Date and Information

Anika Therapeutics last announced its earnings results on May 8th, 2024. The biotechnology company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.13 by $0.04. The company had revenue of $40.52 million for the quarter, compared to analysts' expectations of $39.23 million. Anika Therapeutics has generated ($5.25) earnings per share over the last year (($5.25) diluted earnings per share). Earnings for Anika Therapeutics are expected to grow by 22.22% in the coming year, from $1.08 to $1.32 per share. Anika Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Anika Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/8/2024Q1 2024$0.13$0.09($0.04)$0.49$39.23 million$40.52 million
3/13/2024Q4 2023($0.15)$0.05+$0.20$4.40$41.51 million$42.97 million
8/8/2023Q2 2023($0.27)($0.06)+$0.21$0.07$40.61 million$44.30 million
5/9/2023Q1 2023($0.29)($0.36)($0.07)($0.01)$37.16 million$37.92 million
3/6/2023Q4 2022($0.15)($0.21)($0.06)($0.08)$38.32 million$39.62 million
11/8/2022Q3 2022($0.18)($0.05)+$0.13$0.19$36.56 million$40.26 million
8/3/2022Q2 2022($0.19)($0.12)+$0.07($0.04)$36.40 million$39.66 million    
5/5/2022Q1 2022($0.24)($0.11)+$0.13($0.02)$33.90 million$36.69 million    
3/8/2022Q4 2021-($0.23)($0.23)($0.06)$32.85 million$35.82 million    
11/4/2021Q3 2021($0.21)$0.05+$0.26$0.06$36.45 million$39.54 million    
8/4/2021Q2 2021($0.15)$0.45+$0.60($0.27)$34.51 million$38.15 million    
5/5/2021Q1 2021$0.01$0.20+$0.19($0.08)$32.39 million$34.29 million  
3/3/2021Q4 2020$0.11$0.12+$0.01$1.34$33.49 million$32.69 million  
11/9/2020Q3 2020($0.01)($0.45)($0.44)($0.45)$32.22 million$31.69 million  
7/30/2020Q2 2020($0.21)($0.54)($0.33)$0.72$16.73 million$30.68 million  
5/7/2020Q1 2020$0.40$0.24($0.16)$0.66$36.06 million$35.40 million  
2/20/2020Q4 2019$0.41$0.43+$0.02$0.58$27.63 million$29.77 million
10/24/2019Q3$0.39$0.64+$0.25$0.64$27.01 million$29.70 million  
7/24/2019Q2$0.42$0.67+$0.25$0.67$27.41 million$30.42 million  

Anika Therapeutics Earnings - Frequently Asked Questions

When is Anika Therapeutics's earnings date?

Anika Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on ANIK's earnings history.

Did Anika Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Anika Therapeutics (NASDAQ:ANIK) missed the analysts' consensus estimate of $0.13 by $0.04 with a reported earnings per share (EPS) of $0.09. Learn more on analysts' earnings estimate vs. ANIK's actual earnings.

How much revenue does Anika Therapeutics generate each year?

Anika Therapeutics (NASDAQ:ANIK) has a recorded annual revenue of $166.66 million.

How much profit does Anika Therapeutics generate each year?

Anika Therapeutics (NASDAQ:ANIK) has a recorded net income of -$82.67 million. ANIK has generated -$5.25 earnings per share over the last four quarters.

What is Anika Therapeutics's price-to-earnings ratio?

Anika Therapeutics (NASDAQ:ANIK) has a forward price-to-earnings ratio of 23.74. The price/earnings-to-growth ratio is 2.28.

What is Anika Therapeutics's EPS forecast for next year?

Anika Therapeutics's earnings are expected to grow from $1.08 per share to $1.32 per share in the next year, which is a 22.22% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANIK) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners